Global Transdermal Drug Delivery Systems Market Insights and Forecast to 2028

Report ID: 1538534 | Published Date: Jan 2025 | No. of Page: 111 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Fentanyl
        1.2.3 Nitroglycerin
        1.2.4 Estradiol
        1.2.5 Nicotine
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 OTC
        1.3.3 Rx
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Transdermal Drug Delivery Systems Market Perspective (2017-2028)
    2.2 Transdermal Drug Delivery Systems Growth Trends by Region
        2.2.1 Transdermal Drug Delivery Systems Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Transdermal Drug Delivery Systems Historic Market Size by Region (2017-2022)
        2.2.3 Transdermal Drug Delivery Systems Forecasted Market Size by Region (2023-2028)
    2.3 Transdermal Drug Delivery Systems Market Dynamics
        2.3.1 Transdermal Drug Delivery Systems Industry Trends
        2.3.2 Transdermal Drug Delivery Systems Market Drivers
        2.3.3 Transdermal Drug Delivery Systems Market Challenges
        2.3.4 Transdermal Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Transdermal Drug Delivery Systems Players by Revenue
        3.1.1 Global Top Transdermal Drug Delivery Systems Players by Revenue (2017-2022)
        3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2017-2022)
    3.2 Global Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
    3.4 Global Transdermal Drug Delivery Systems Market Concentration Ratio
        3.4.1 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Systems Revenue in 2021
    3.5 Transdermal Drug Delivery Systems Key Players Head office and Area Served
    3.6 Key Players Transdermal Drug Delivery Systems Product Solution and Service
    3.7 Date of Enter into Transdermal Drug Delivery Systems Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery Systems Breakdown Data by Type
    4.1 Global Transdermal Drug Delivery Systems Historic Market Size by Type (2017-2022)
    4.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2023-2028)
5 Transdermal Drug Delivery Systems Breakdown Data by Application
    5.1 Global Transdermal Drug Delivery Systems Historic Market Size by Application (2017-2022)
    5.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Transdermal Drug Delivery Systems Market Size (2017-2028)
    6.2 North America Transdermal Drug Delivery Systems Market Size by Type
        6.2.1 North America Transdermal Drug Delivery Systems Market Size by Type (2017-2022)
        6.2.2 North America Transdermal Drug Delivery Systems Market Size by Type (2023-2028)
        6.2.3 North America Transdermal Drug Delivery Systems Market Share by Type (2017-2028)
    6.3 North America Transdermal Drug Delivery Systems Market Size by Application
        6.3.1 North America Transdermal Drug Delivery Systems Market Size by Application (2017-2022)
        6.3.2 North America Transdermal Drug Delivery Systems Market Size by Application (2023-2028)
        6.3.3 North America Transdermal Drug Delivery Systems Market Share by Application (2017-2028)
    6.4 North America Transdermal Drug Delivery Systems Market Size by Country
        6.4.1 North America Transdermal Drug Delivery Systems Market Size by Country (2017-2022)
        6.4.2 North America Transdermal Drug Delivery Systems Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Transdermal Drug Delivery Systems Market Size (2017-2028)
    7.2 Europe Transdermal Drug Delivery Systems Market Size by Type
        7.2.1 Europe Transdermal Drug Delivery Systems Market Size by Type (2017-2022)
        7.2.2 Europe Transdermal Drug Delivery Systems Market Size by Type (2023-2028)
        7.2.3 Europe Transdermal Drug Delivery Systems Market Share by Type (2017-2028)
    7.3 Europe Transdermal Drug Delivery Systems Market Size by Application
        7.3.1 Europe Transdermal Drug Delivery Systems Market Size by Application (2017-2022)
        7.3.2 Europe Transdermal Drug Delivery Systems Market Size by Application (2023-2028)
        7.3.3 Europe Transdermal Drug Delivery Systems Market Share by Application (2017-2028)
    7.4 Europe Transdermal Drug Delivery Systems Market Size by Country
        7.4.1 Europe Transdermal Drug Delivery Systems Market Size by Country (2017-2022)
        7.4.2 Europe Transdermal Drug Delivery Systems Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size (2017-2028)
    8.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type
        8.2.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Transdermal Drug Delivery Systems Market Share by Type (2017-2028)
    8.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application
        8.3.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Transdermal Drug Delivery Systems Market Share by Application (2017-2028)
    8.4 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region
        8.4.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Transdermal Drug Delivery Systems Market Size (2017-2028)
    9.2 Latin America Transdermal Drug Delivery Systems Market Size by Type
        9.2.1 Latin America Transdermal Drug Delivery Systems Market Size by Type (2017-2022)
        9.2.2 Latin America Transdermal Drug Delivery Systems Market Size by Type (2023-2028)
        9.2.3 Latin America Transdermal Drug Delivery Systems Market Share by Type (2017-2028)
    9.3 Latin America Transdermal Drug Delivery Systems Market Size by Application
        9.3.1 Latin America Transdermal Drug Delivery Systems Market Size by Application (2017-2022)
        9.3.2 Latin America Transdermal Drug Delivery Systems Market Size by Application (2023-2028)
        9.3.3 Latin America Transdermal Drug Delivery Systems Market Share by Application (2017-2028)
    9.4 Latin America Transdermal Drug Delivery Systems Market Size by Country
        9.4.1 Latin America Transdermal Drug Delivery Systems Market Size by Country (2017-2022)
        9.4.2 Latin America Transdermal Drug Delivery Systems Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size (2017-2028)
    10.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type
        10.2.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Transdermal Drug Delivery Systems Market Share by Type (2017-2028)
    10.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application
        10.3.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Transdermal Drug Delivery Systems Market Share by Application (2017-2028)
    10.4 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country
        10.4.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Hisamitsu
        11.1.1 Hisamitsu Company Details
        11.1.2 Hisamitsu Business Overview
        11.1.3 Hisamitsu Transdermal Drug Delivery Systems Introduction
        11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.1.5 Hisamitsu Recent Developments
    11.2 Mylan
        11.2.1 Mylan Company Details
        11.2.2 Mylan Business Overview
        11.2.3 Mylan Transdermal Drug Delivery Systems Introduction
        11.2.4 Mylan Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.2.5 Mylan Recent Developments
    11.3 GSK
        11.3.1 GSK Company Details
        11.3.2 GSK Business Overview
        11.3.3 GSK Transdermal Drug Delivery Systems Introduction
        11.3.4 GSK Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.3.5 GSK Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Transdermal Drug Delivery Systems Introduction
        11.4.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 Teve (Actavis)
        11.5.1 Teve (Actavis) Company Details
        11.5.2 Teve (Actavis) Business Overview
        11.5.3 Teve (Actavis) Transdermal Drug Delivery Systems Introduction
        11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.5.5 Teve (Actavis) Recent Developments
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Details
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Introduction
        11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.6.5 Johnson & Johnson Recent Developments
    11.7 Lohmann
        11.7.1 Lohmann Company Details
        11.7.2 Lohmann Business Overview
        11.7.3 Lohmann Transdermal Drug Delivery Systems Introduction
        11.7.4 Lohmann Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.7.5 Lohmann Recent Developments
    11.8 Teikoku Seiyaku
        11.8.1 Teikoku Seiyaku Company Details
        11.8.2 Teikoku Seiyaku Business Overview
        11.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Introduction
        11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.8.5 Teikoku Seiyaku Recent Developments
    11.9 Bayer
        11.9.1 Bayer Company Details
        11.9.2 Bayer Business Overview
        11.9.3 Bayer Transdermal Drug Delivery Systems Introduction
        11.9.4 Bayer Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.9.5 Bayer Recent Developments
    11.10 Novartis
        11.10.1 Novartis Company Details
        11.10.2 Novartis Business Overview
        11.10.3 Novartis Transdermal Drug Delivery Systems Introduction
        11.10.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.10.5 Novartis Recent Developments
    11.11 Teve (Actavis)
        11.11.1 Teve (Actavis) Company Details
        11.11.2 Teve (Actavis) Business Overview
        11.11.3 Teve (Actavis) Transdermal Drug Delivery Systems Introduction
        11.11.4 Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.11.5 Teve (Actavis) Recent Developments
    11.12 Qizheng
        11.12.1 Qizheng Company Details
        11.12.2 Qizheng Business Overview
        11.12.3 Qizheng Transdermal Drug Delivery Systems Introduction
        11.12.4 Qizheng Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.12.5 Qizheng Recent Developments
    11.13 Endo
        11.13.1 Endo Company Details
        11.13.2 Endo Business Overview
        11.13.3 Endo Transdermal Drug Delivery Systems Introduction
        11.13.4 Endo Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.13.5 Endo Recent Developments
    11.14 Huarun 999
        11.14.1 Huarun 999 Company Details
        11.14.2 Huarun 999 Business Overview
        11.14.3 Huarun 999 Transdermal Drug Delivery Systems Introduction
        11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.14.5 Huarun 999 Recent Developments
    11.15 Haw Par
        11.15.1 Haw Par Company Details
        11.15.2 Haw Par Business Overview
        11.15.3 Haw Par Transdermal Drug Delivery Systems Introduction
        11.15.4 Haw Par Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.15.5 Haw Par Recent Developments
    11.16 Nichiban
        11.16.1 Nichiban Company Details
        11.16.2 Nichiban Business Overview
        11.16.3 Nichiban Transdermal Drug Delivery Systems Introduction
        11.16.4 Nichiban Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.16.5 Nichiban Recent Developments
    11.17 Mentholatum
        11.17.1 Mentholatum Company Details
        11.17.2 Mentholatum Business Overview
        11.17.3 Mentholatum Transdermal Drug Delivery Systems Introduction
        11.17.4 Mentholatum Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.17.5 Mentholatum Recent Developments
    11.18 Laboratoires Genevrier
        11.18.1 Laboratoires Genevrier Company Details
        11.18.2 Laboratoires Genevrier Business Overview
        11.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Introduction
        11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2017-2022)
        11.18.5 Laboratoires Genevrier Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Fentanyl
    Table 3. Key Players of Nitroglycerin
    Table 4. Key Players of Estradiol
    Table 5. Key Players of Nicotine
    Table 6. Key Players of Other
    Table 7. Global Transdermal Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Transdermal Drug Delivery Systems Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Transdermal Drug Delivery Systems Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Transdermal Drug Delivery Systems Market Share by Region (2017-2022)
    Table 11. Global Transdermal Drug Delivery Systems Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Transdermal Drug Delivery Systems Market Share by Region (2023-2028)
    Table 13. Transdermal Drug Delivery Systems Market Trends
    Table 14. Transdermal Drug Delivery Systems Market Drivers
    Table 15. Transdermal Drug Delivery Systems Market Challenges
    Table 16. Transdermal Drug Delivery Systems Market Restraints
    Table 17. Global Transdermal Drug Delivery Systems Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Transdermal Drug Delivery Systems Revenue Share by Players (2017-2022)
    Table 19. Global Top Transdermal Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery Systems as of 2021)
    Table 20. Ranking of Global Top Transdermal Drug Delivery Systems Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery Systems Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Transdermal Drug Delivery Systems Product Solution and Service
    Table 24. Date of Enter into Transdermal Drug Delivery Systems Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2017-2022)
    Table 28. Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2023-2028)
    Table 30. Global Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Transdermal Drug Delivery Systems Revenue Share by Application (2017-2022)
    Table 32. Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Transdermal Drug Delivery Systems Revenue Share by Application (2023-2028)
    Table 34. North America Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Transdermal Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Transdermal Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Transdermal Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Transdermal Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Transdermal Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Transdermal Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Transdermal Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Transdermal Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Transdermal Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Transdermal Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Transdermal Drug Delivery Systems Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Transdermal Drug Delivery Systems Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Transdermal Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Transdermal Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Transdermal Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Transdermal Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Transdermal Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Transdermal Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Transdermal Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Transdermal Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Hisamitsu Company Details
    Table 65. Hisamitsu Business Overview
    Table 66. Hisamitsu Transdermal Drug Delivery Systems Product
    Table 67. Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 68. Hisamitsu Recent Developments
    Table 69. Mylan Company Details
    Table 70. Mylan Business Overview
    Table 71. Mylan Transdermal Drug Delivery Systems Product
    Table 72. Mylan Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 73. Mylan Recent Developments
    Table 74. GSK Company Details
    Table 75. GSK Business Overview
    Table 76. GSK Transdermal Drug Delivery Systems Product
    Table 77. GSK Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 78. GSK Recent Developments
    Table 79. Novartis Company Details
    Table 80. Novartis Business Overview
    Table 81. Novartis Transdermal Drug Delivery Systems Product
    Table 82. Novartis Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 83. Novartis Recent Developments
    Table 84. Teve (Actavis) Company Details
    Table 85. Teve (Actavis) Business Overview
    Table 86. Teve (Actavis) Transdermal Drug Delivery Systems Product
    Table 87. Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 88. Teve (Actavis) Recent Developments
    Table 89. Johnson & Johnson Company Details
    Table 90. Johnson & Johnson Business Overview
    Table 91. Johnson & Johnson Transdermal Drug Delivery Systems Product
    Table 92. Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 93. Johnson & Johnson Recent Developments
    Table 94. Lohmann Company Details
    Table 95. Lohmann Business Overview
    Table 96. Lohmann Transdermal Drug Delivery Systems Product
    Table 97. Lohmann Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 98. Lohmann Recent Developments
    Table 99. Teikoku Seiyaku Company Details
    Table 100. Teikoku Seiyaku Business Overview
    Table 101. Teikoku Seiyaku Transdermal Drug Delivery Systems Product
    Table 102. Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 103. Teikoku Seiyaku Recent Developments
    Table 104. Bayer Company Details
    Table 105. Bayer Business Overview
    Table 106. Bayer Transdermal Drug Delivery Systems Product
    Table 107. Bayer Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 108. Bayer Recent Developments
    Table 109. Novartis Company Details
    Table 110. Novartis Business Overview
    Table 111. Novartis Transdermal Drug Delivery Systems Product
    Table 112. Novartis Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 113. Novartis Recent Developments
    Table 114. Teve (Actavis) Company Details
    Table 115. Teve (Actavis) Business Overview
    Table 116. Teve (Actavis) Transdermal Drug Delivery Systems Product
    Table 117. Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 118. Teve (Actavis) Recent Developments
    Table 119. Qizheng Company Details
    Table 120. Qizheng Business Overview
    Table 121. Qizheng Transdermal Drug Delivery Systems Product
    Table 122. Qizheng Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 123. Qizheng Recent Developments
    Table 124. Endo Company Details
    Table 125. Endo Business Overview
    Table 126. Endo Transdermal Drug Delivery Systems Product
    Table 127. Endo Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 128. Endo Recent Developments
    Table 129. Huarun 999 Company Details
    Table 130. Huarun 999 Business Overview
    Table 131. Huarun 999 Transdermal Drug Delivery Systems Product
    Table 132. Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 133. Huarun 999 Recent Developments
    Table 134. Haw Par Company Details
    Table 135. Haw Par Business Overview
    Table 136. Haw Par Transdermal Drug Delivery Systems Product
    Table 137. Haw Par Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 138. Haw Par Recent Developments
    Table 139. Nichiban Company Details
    Table 140. Nichiban Business Overview
    Table 141. Nichiban Transdermal Drug Delivery Systems Product
    Table 142. Nichiban Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 143. Nichiban Recent Developments
    Table 144. Mentholatum Company Details
    Table 145. Mentholatum Business Overview
    Table 146. Mentholatum Transdermal Drug Delivery Systems Product
    Table 147. Mentholatum Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 148. Mentholatum Recent Developments
    Table 149. Laboratoires Genevrier Company Details
    Table 150. Laboratoires Genevrier Business Overview
    Table 151. Laboratoires Genevrier Transdermal Drug Delivery Systems Product
    Table 152. Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 153. Laboratoires Genevrier Recent Developments
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Transdermal Drug Delivery Systems Market Share by Type: 2021 VS 2028
    Figure 2. Fentanyl Features
    Figure 3. Nitroglycerin Features
    Figure 4. Estradiol Features
    Figure 5. Nicotine Features
    Figure 6. Other Features
    Figure 7. Global Transdermal Drug Delivery Systems Market Share by Application: 2021 VS 2028
    Figure 8. OTC Case Studies
    Figure 9. Rx Case Studies
    Figure 10. Transdermal Drug Delivery Systems Report Years Considered
    Figure 11. Global Transdermal Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Transdermal Drug Delivery Systems Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Transdermal Drug Delivery Systems Market Share by Region: 2021 VS 2028
    Figure 14. Global Transdermal Drug Delivery Systems Market Share by Players in 2021
    Figure 15. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery Systems as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery Systems Revenue in 2021
    Figure 17. North America Transdermal Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2028)
    Figure 19. North America Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2028)
    Figure 20. North America Transdermal Drug Delivery Systems Market Size Share by Country (2017-2028)
    Figure 21. United States Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Transdermal Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Transdermal Drug Delivery Systems Market Size Share by Country (2017-2028)
    Figure 27. Germany Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Transdermal Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Transdermal Drug Delivery Systems Market Size Share by Region (2017-2028)
    Figure 37. China Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Transdermal Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Transdermal Drug Delivery Systems Market Size Share by Country (2017-2028)
    Figure 47. Mexico Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Transdermal Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Transdermal Drug Delivery Systems Market Size Share by Country (2017-2028)
    Figure 53. Turkey Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Transdermal Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 57. Mylan Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 58. GSK Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 60. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 61. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 62. Lohmann Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 63. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 64. Bayer Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 65. Novartis Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 66. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 67. Qizheng Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 68. Endo Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 69. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 70. Haw Par Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 71. Nichiban Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 72. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 73. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Novartis
Teve (Actavis)
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Frequently Asked Questions
Transdermal Drug Delivery Systems report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Transdermal Drug Delivery Systems report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Transdermal Drug Delivery Systems report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Travel Bag

Travel Bag market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More

Travel Retail

Travel Retail market is segmented by players, region (country), by Type and by Application. Playe ... Read More

Ultra-Mobile Devices

Ultra-Mobile Devices market is segmented by Type and by Application. Players, stakeholders, and o ... Read More